Last updated 4 days ago

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy

26 patients around the world
Available in Brazil, United States
Lexeo Therapeutics
5Research sites
26Patients around the world

This study is for people with

Ataxia
Friedreich's ataxia

Requirements for the patient

From 6 Years
All Gender

Medical requirements

Male or female, age at least 6 years at the time of signing the informed consent (and assent, if applicable).
Diagnosis of FA, based on clinical phenotype and genotype (GAA expansion on the frataxin gene).
Onset of FA on or before 25 years of age.
Confirmed left ventricular hypertrophy and abnormal left ventricular mass index.
Left ventricular ejection fraction at least 30%.
Anti-AAVrh.10 total antibody titer less than the protocol-specified maximum level.
Presence of other forms of cardiomyopathy that contribute to heart failure.
Current use of inotrope infusion or presence of a ventricular assist device.
Contraindication to cardiac MRI.
Prior organ transplant.
Previous gene transfer or cell therapy.
Poorly controlled diabetes (hemoglobin A1c ≥8%).
Active hematologic or solid organ cancer.

Sites

Hospital Universitário Walter Cantídio - Universidade Federal do Ceará - Fortaleza, Ceara
R. Coronel Nunes de Melo, 1142 - Rodolfo Teófilo, Fortaleza - CE, 60430-275, Brazil
Hospital São Rafael
Av. São Rafael, 2152 - São Marcos, Salvador - BA, 41253-190
Hospital Das Clínicas Da Universidade Federal de Minas Gerais - UFMG
Av. Prof. Alfredo Balena, 110 2 floor - Room 216 - Santa Efigênia, Belo Horizonte - MG, 30130-100
Hospital de Clínicas - Universidade Estadual de Campinas - UNICAMP
R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888
Hospital das Clínicas de Ribeirão Preto
Campus Universitário S/N, Bloco G Subsolo II, Monte Alegre, Ribeirão Preto, Sao Paulo
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy